Patents by Inventor Bob Rosen

Bob Rosen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Additional artemisinin and berberine compositions and methods of making
    Patent number: 9358261
    Abstract: An Alternative ACT composition consisting of natural botanical active ingredients, all of which are GRAS (generally regarded as safe by the FDA). The novel Artemisinin Combination Therapy (ACT) consists of artemisinin and its derivatives, berberine, capsaicin, and papaya extract. The four active substances mixed with various selected excipient compounds to form a single pill, tablet or capsule for the treatment and prevention of chikungunya.
    Type: Grant
    Filed: November 5, 2015
    Date of Patent: June 7, 2016
    Assignee: U.S. Phytotherapy, Inc.
    Inventor: Bob Rosen
  • Additional Artemisinin and Berberine Compositions and Methods of Making
    Publication number: 20160058809
    Abstract: An Alternative ACT composition consisting of natural botanical active ingredients, all of which are GRAS (generally regarded as safe by the FDA). The novel Artemisinin Combination Therapy (ACT) consists of artemisinin and its derivatives, berberine, capsaicin, and papaya extract. The four active substances mixed with various selected excipient compounds to form a single pill, tablet or capsule for the treatment and prevention of chikungunya.
    Type: Application
    Filed: November 5, 2015
    Publication date: March 3, 2016
    Inventor: Bob Rosen
  • Artemisinin with berberine compositions and methods of making
    Patent number: 9186331
    Abstract: An all-natural herbal composition and methods of preparing the same are provided. The novel Artemisinin Combination Therapy (ACT) consists of artemisinin and its derivatives and berberine, the two active substances mixed with various selected excipient compounds to form a single pill, tablet or capsule for treatment and prevention of malaria, dengue fever, yellow fever, dysentery, Lyme disease, babesiosis, progressive multifocal leukoencephalopathy, Helicobacter Pylori, and colitis, in adults and children. A tablet or pill for children is formulated to be chewable.
    Type: Grant
    Filed: February 5, 2015
    Date of Patent: November 17, 2015
    Assignee: U.S. Phytotherapy, Inc.
    Inventors: Bob Rosen, Andreas Muehler, Jan Mintorovitch, Karan Arora, David Perez, Nicholas A. Perez, Tejas D. Choksi
  • Artemisinin with Berberine Compositions and Methods of Making
    Publication number: 20150148364
    Abstract: An all-natural herbal composition and methods of preparing the same are provided. The novel Artemisinin Combination Therapy (ACT) consists of artemisinin and its derivatives and berberine, the two active substances mixed with various selected excipient compounds to form a single pill, tablet or capsule for treatment and prevention of malaria, dengue fever, yellow fever, dysentery, Lyme disease, babesiosis, progressive multifocal leukoencephalopathy, Helicobacter Pylori, and colitis, in adults and children. A tablet or pill for children is formulated to be chewable.
    Type: Application
    Filed: February 5, 2015
    Publication date: May 28, 2015
    Inventors: Bob Rosen, Andreas Muehler, Jan Mintorovitch, Karan Arora, David Perez, Nicholas A. Perez, Tejas D. Choksi
  • Artemisinin with berberine compositions and methods of making
    Patent number: 9011892
    Abstract: An all-natural herbal composition and methods of preparing the same are provided. The novel Artemisinin Combination Therapy (ACT) consists of artemisinin and its derivatives and berberine, the two active substances mixed with various selected excipient compounds to form a single pill, tablet or capsule for treatment and prevention of malaria, dengue fever, yellow fever, dysentery, Lyme disease, babesiosis, progressive multifocal leukoencephalopathy, Helicobacter Pylori, and colitis, in adults and children. A tablet or pill for children is formulated to be chewable.
    Type: Grant
    Filed: October 25, 2012
    Date of Patent: April 21, 2015
    Assignee: U.S. Phytotherapy, Inc.
    Inventors: Bob Rosen, Andreas Muehler, Jan Mintorovitch, Karan Arora, David Perez, Nicholas Ari Perez, Tejas D. Choksi